Alaunos Therapeutics, Inc.
TCRT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $5,261,124 | $8,130 | $2,354 | $3,058 |
| - Cash | $1,938 | $2,879 | $319 | $1,091 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $5,259,186 | $5,251 | $2,035 | $1,967 |
| Revenue | $0 | $0 | $2 | $4 |
| % Growth | – | -100% | -50% | – |
| Gross Profit | $0 | -$185 | $2 | $4 |
| % Margin | – | – | 100% | 100% |
| EBITDA | -$1,159 | -$1,039 | -$1,073 | -$742 |
| % Margin | – | – | -53,650% | -18,550% |
| Net Income | -$1,159 | -$1,051 | -$1,073 | -$742 |
| % Margin | – | – | -53,650% | -18,550% |
| EPS Diluted | -0.55 | -0.63 | -0.67 | -0.46 |
| % Growth | 12.7% | 6% | -45.7% | – |
| Operating Cash Flow | -$844 | -$701 | -$772 | -$592 |
| Capital Expenditures | -$97 | $0 | $0 | $0 |
| Free Cash Flow | -$941 | -$701 | -$772 | -$592 |